• News

    News from Oxford Biosystems

    News from Oxford Biosystems

From category archives: Oxford Biosystems Latest News

Point of Care

Neutralising SARS-CoV-2 antibodies

The Spike Protein of SARS-CoV-2 is a trimer made up of S1 and S2 proteins.

The Receptor Binding Domain (RBD) of S1 binds to the ACE2 receptor in the cell membrane to gain access to the host cell. Spike antigens trigger the host’s cellular immune system resulting in the B cells producing antibodies against Spike antigens.

Read the rest of entry »

Improve Clinical Management

Influenza is an acute viral infection of the respiratory tract that can cause...

Read the rest of entry »

SD Biosensor immunoassay system

A new rapid, easy-to-use diagnostics platform for point of care use…

Read the rest of entry »

Urinary Antigen Testing

Pneumonia is a common illness affecting approximately 450 million people a year and occurring in all parts of the world. It is a major cause of death among all age groups, resulting in 4 million deaths annually – 7% of total world annual deaths.1

Read the rest of entry »

point-of-care test

GPs should use point-of-care test to guide antibiotic use for pneumonia, says NICE

Draft recommendations from NICE say GPs should consider using a point-of-care test to help decide whether patients presenting with mild pneumonia need antibiotics. Full article in PULSE (June2014).

Oxford Biosystems

184B Park Drive
Milton Park
OX14 4SE

Oxford Biosystems has pledged to be an Antibiotic Guardian

members of